A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Trial Profile

A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs Adalimumab (Primary) ; Azathioprine; Mercaptopurine
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors AbbVie
  • Most Recent Events

    • 09 Sep 2013 Actual initiation date changed from Apr 2013 to May 2013 as reported by ClinicalTrials.gov.
    • 14 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top